Holistic Care: Managing Metabolic Comorbidities in HS Patients

Why is HS management moving beyond the skin?

HS is strongly associated with metabolic syndrome, polycystic ovary syndrome (PCOS), and cardiovascular disease. Modern treatment strategies are shifting toward a "multidisciplinary team" approach where dermatologists collaborate with endocrinologists and nutritionists to manage the systemic nature of the disease.

How does HS Comorbidity Management Trends impact drug portfolios?

Pharmaceutical companies with diverse portfolios (addressing both inflammation and metabolic health) are best positioned for success. Current HS Comorbidity Management Trends show a rising use of GLP-1 agonists and metformin as adjuncts to biologics to reduce systemic inflammation through weight management in 2024 and 2025.

The impact of obesity on biologic efficacy

Clinical data confirms that higher BMI can reduce the effectiveness of fixed-dose biologics. In 2025, the market will see a shift toward "weight-based dosing" or more potent therapies for patients with high metabolic burdens to ensure clinical outcomes are met.

• Integration of nutrition counseling in HS clinics.
• Rising use of cardiovascular screening in HS patients.
• Focus on smoking cessation as a primary therapeutic adjunct.

Strategic Trends for 2024/2025

In 2025, we expect the emergence of "Comprehensive HS Centers of Excellence." These centers will provide one-stop care for the skin, heart, and metabolic health, driving higher patient loyalty and better overall health outcomes.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com